Endogenous IGF-I and αVβ3 Integrin Ligands Regulate Increased Smooth Muscle Hyperplasia in Stricturing Crohn's Disease
Open Access
- 31 January 2010
- journal article
- Published by Elsevier BV in Gastroenterology
- Vol. 138 (1), 285-293
- https://doi.org/10.1053/j.gastro.2009.09.003
Abstract
No abstract availableFunding Information
- National Institute of Diabetes and Digestive and Kidney Diseases
This publication has 41 references indexed in Scilit:
- Differential changes in brain‐derived neurotrophic factor and extracellular signal‐regulated kinase in rat primary afferent pathways with colitisNeurogastroenterology & Motility, 2008
- Pathogenic angiogenesis in IBD and experimental colitis: new ideas and therapeutic avenuesAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2007
- Angiogenesis blockade as a new therapeutic approach to experimental colitisGut, 2007
- Differential Angiogenic Regulation of Experimental ColitisThe American Journal of Pathology, 2006
- Endogenous IGF-I protects human intestinal smooth muscle cells from apoptosis by regulation of GSK-3β activityAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2005
- Erratum: Integrins in regulation of tissue development and function. J Pathol; 200: 471–480The Journal of Pathology, 2003
- Integrins in regulation of tissue development and functionThe Journal of Pathology, 2003
- Coupling of the Insulin-like Growth Factor-I Receptor Tyrosine Kinase to Gi2 in Human Intestinal Smooth MusclePublished by Elsevier BV ,2001
- Targeted overexpression of IGF-I evokes distinct patterns of organ remodeling in smooth muscle cell tissue beds of transgenic mice.JCI Insight, 1997
- The expression of integrins and cadherins in normal human uterus and uterine leiomyomasAmerican Journal of Obstetrics and Gynecology, 1996